Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001401914-21-000103
Filing Date
2021-06-24
Accepted
2021-06-24 17:00:56
Documents
1
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162456842200952.html 4  
1 FORM 4 wf-form4_162456842200952.xml 4 4053
  Complete submission text file 0001401914-21-000103.txt   5608
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address
Steele Robin Joan (Reporting) CIK: 0001301008 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 211043582

Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Issuer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations